Boston Common Asset Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.3M Buy
250,152
+16,502
+7% +$1.47M 1.37% 15
2025
Q4
$18.5M Sell
233,650
-62,088
-21% -$4.87M 1.11% 20
2025
Q3
$23.6M Sell
295,738
-6,813
-2% -$581K 0.66% 42
2025
Q2
$27.5M Buy
302,551
+6,572
+2% +$600K 0.77% 37
2025
Q1
$27.7M Buy
295,979
+27,531
+10% +$2.47M 0.84% 28
2024
Q4
$24.4M Buy
268,448
+93,121
+53% +$8.89M 0.71% 36
2024
Q3
$18.2M Sell
175,327
-635
-0.4% -$64.7K 0.47% 80
2024
Q2
$17.1M Sell
175,962
-13,154
-7% -$1.21M 0.44% 90
2024
Q1
$17M Sell
189,116
-78,046
-29% -$6.61M 0.41% 94
2023
Q4
$21.3M Buy
267,162
+393
+0.1% +$29.5K 0.48% 79
2023
Q3
$19M Sell
266,769
-43,478
-14% -$3.25M 0.45% 82
2023
Q2
$23.9M Buy
310,247
+56,608
+22% +$4.38M 0.51% 76
2023
Q1
$19.1M Sell
253,639
-8,418
-3% -$626K 0.4% 95
2022
Q4
$20.6M Buy
262,057
+11,796
+5% +$884K 0.99% 36
2022
Q3
$17.6M Buy
250,261
+10,742
+4% +$842K 0.92% 37
2022
Q2
$19.2M Sell
239,519
-1,035
-0.4% -$80.9K 0.96% 35
2022
Q1
$18.2M Buy
240,554
+1,645
+0.7% +$130K 0.79% 44
2021
Q4
$20.4M Buy
238,909
+2,887
+1% +$225K 0.82% 44
2021
Q3
$17.8M Buy
236,022
+600
+0.3% +$47.6K 0.77% 47
2021
Q2
$19.2M Buy
235,422
+78,767
+50% +$6.44M 0.82% 45
2021
Q1
$12.3M Buy
156,655
+26,510
+20% +$2.08M 0.78% 40
2020
Q4
$11.1M Buy
130,145
+36,545
+39% +$3.02M 0.78% 43
2020
Q3
$7.22M Buy
93,600
+251
+0.3% +$19.1K 0.69% 46
2020
Q2
$6.84M Buy
93,349
+11,383
+14% +$809K 0.73% 47
2020
Q1
$5.44M Sell
81,966
-733
-0.9% -$51.7K 0.77% 48
2019
Q4
$5.69M Sell
82,699
-21,241
-20% -$1.45M 0.66% 55
2019
Q3
$7.64M Sell
103,940
-1,139
-1% -$82.6K 0.94% 33
2019
Q2
$7.53M Sell
105,079
-2,513
-2% -$178K 0.94% 33
2019
Q1
$7.37M Buy
107,592
+5,575
+5% +$360K 0.96% 30
2018
Q4
$6.07M Buy
102,017
+4,689
+5% +$293K 0.89% 38
2018
Q3
$6.52M Sell
97,328
-3,828
-4% -$255K 0.81% 46
2018
Q2
$6.56M Sell
101,156
-11,524
-10% -$754K 0.81% 49
2018
Q1
$8.08M Sell
112,680
-938
-0.8% -$67.5K 0.95% 31
2017
Q4
$8.57M Buy
113,618
+19,016
+20% +$1.39M 1.02% 25
2017
Q3
$6.89M Buy
94,602
+1,925
+2% +$139K 0.86% 37
2017
Q2
$6.87M Buy
92,677
+24,932
+37% +$1.85M 0.9% 31
2017
Q1
$4.96M Buy
67,745
+11,630
+21% +$814K 0.67% 53
2016
Q4
$3.67M Buy
56,115
+1
+0% +$69 0.54% 73
2016
Q3
$4.16M Sell
56,114
-647
-1% -$47.8K 0.23% 127
2016
Q2
$4.16M Sell
56,761
-1,195
-2% -$85.1K 0.24% 127
2016
Q1
$4.09M Sell
57,956
-710
-1% -$47.2K 0.23% 127
2015
Q4
$3.91M Sell
58,666
-3,785
-6% -$252K 0.22% 131
2015
Q3
$3.96M Sell
62,451
-1,456
-2% -$95.1K 0.24% 124
2015
Q2
$4.18M Sell
63,907
-1,580
-2% -$107K 0.22% 132
2015
Q1
$4.54M Buy
65,487
+893
+1% +$61.7K 0.24% 126
2014
Q4
$4.47M Sell
64,594
-217
-0.3% -$14.7K 0.25% 126
2014
Q3
$4.23M Buy
64,811
+2,495
+4% +$165K 0.24% 136
2014
Q2
$4.25M Buy
62,316
+293
+0.5% +$19.6K 0.23% 134
2014
Q1
$4.02M Buy
62,023
+15
+0% +$945 0.23% 136
2013
Q4
$4.04M Sell
62,008
-11,781
-16% -$754K 0.23% 134
2013
Q3
$4.38M Sell
73,789
-2,740
-4% -$162K 0.25% 131
2013
Q2
$4.38M Buy
+76,529
New +$4.54M 0.27% 127

Other funds holding CL